FDA Launches Webpage Allowing Anonymous Reports of Regulatory Misconduct Regarding Medical Devices
ABSTRACT: One week before Halloween 2016 and the FDA just launched a new webpage titled "Reporting Allegations of Regulatory Misconduct" which allows anyone to report alleged misconduct on the part of medical device manufacturers or individuals marketing medical devices.
On October 24, 2016, the FDA announced the launch of a new webpage at fda.gov titled “Reporting Allegations of Regulatory Misconduct.” The new webpage allows anyone to “file a complaint reporting an allegation of regulatory misconduct” by medical device manufacturers or individuals marketing medical devices. Although the FDA encourages people making the reports of alleged regulatory misconduct to provide contact information, the new webpage permits anonymous reporting. Thus, reports can be made without ever knowing the source or the agenda of the person making the report.
According to the announcement for the new webpage, this new reporting process “can help make the FDA aware of regulatory concerns it may not learn of otherwise.” The new webpage includes a table of examples of allegations. The table includes claims that manufacturers or individuals are promoting devices for off-label uses; failure of manufacturers to submit required medical device safety reports (MDRs); failure to meet design or manufacturing responsibilities; marketing a device with 510(k) clearance or PMA approval; and several violations concerning importation or registration of devices. Of course, the list also includes the catch-all of a manufacturer knowingly deceiving the FDA by hiding information or falsifying documents.
The new webpage makes it easy to submit a report by simply clicking on the “Allegations of Regulatory Misconduct Form” link under the question “How do I submit an allegation about a medical device manufacturer to the FDA?” which is located in the middle of the page. The form itself is also quite simple and merely asks the reporter to complete six sections along with the reporter’s name and email address if the reporter wants to provide identifying information. The six categories of information on the form are:
- Name of the company;
- Address of the company, if known;
- Telephone number of the company, if known;
- Name of the device and model (if applicable);
- Lot numbers/serial numbers/part numbers;
- Detailed description of the allegation with any available supporting documentation.
According to the FDA, it will prioritize review of allegations “based on the level of potential risks, within the context of an overall benefit-risk profile, to patients.” Based on the FDA’s investigation into the allegations, it expressly advises that it might issue warning letters, inspect the manufacturer’s facilities or request a device recall.
While patient advocates may applaud the launch of this new webpage, medical device manufacturers and their employees might justifiably be concerned about abuse of this new reporting process. Plaintiffs’ lawyers already use the citizen petition process to try to bolster claims against pharmaceutical and medical device manufacturers. A defense lawyer does not need an overactive imagination to conjure scenarios in which lawyers encourage (or even make) these reports to enhance their litigation claims, including qui tam claims, against device manufacturers. Likewise, individuals could abuse the system by falsely making claims against other individuals. One such easy to imagine scenario would be a sales representative anonymously claiming that a competitor’s sales representative is promoting a device for off-label uses. If the FDA’s investigation includes gathering information from the doctors to whom the alleged off-label promoting sales representative markets the device, then the damage to that individual’s reputation could be substantial even though the report might be unsubstantiated.
Device manufacturers and their employees should be aware of the new webpage and be prepared to respond to FDA investigations concerning reports made on the new webpage.
related services

Cybersecurity Check-Up: Always A Good Time To Prepare to Protect ...

All Claims Means ALL: The PREP Act Provides Immunity in COVID-19 Vaccination Case ...
About Drug / Device Law Blog
Baker Sterchi's Drug / Device Law Blog examines topics and legal developments of interest to the drug and device industry. Learn more about the editor, Paul Penticuff, and our Drug and Device practice.
Subscribe via email
Subscribe to rss feeds
RSS FeedsABOUT baker sterchi blogs
Baker Sterchi Cowden & Rice LLC (Baker Sterchi) publishes this website as a service to our clients, colleagues and others, for informational purposes only. These materials are not intended to create an attorney-client relationship, and are not a substitute for sound legal advice. You should not base any action or lack of action on any information included in our website, without first seeking appropriate legal or other professional advice. If you contact us through our website or via email, no attorney-client relationship is created, and no confidential information should be transmitted. Communication with Baker Sterchi by e-mail or other transmissions over the Internet may not be secure, and you should not send confidential electronic messages that are not adequately encrypted.
The hiring of an attorney is an important decision, which should not be based solely on information appearing on our website. To the extent our website has provided links to other Internet resources, those links are not under our control, and we are not responsible for their content. We do our best to provide you current, accurate information; however, we cannot guarantee that this information is the most current, correct or complete. In addition, you should not take this information as a promise or indication of future results.
Disclaimer
The Drug / Device Law Blog is made available by Baker Sterchi Cowden & Rice LLC for educational purposes only as well as to give you general information and a general understanding of the law, not to provide specific legal advice. Your use of this blog site alone creates no attorney client relationship between you and the firm.
Confidential information
Do not include confidential information in comments or other feedback or messages related to the Drug / Device Law Blog, as these are neither confidential nor secure methods of communicating with attorneys. The Drug / Device Law Blog should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.